Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Rebound, Stratagene Shares Fall Again

Shares of Bruker Biosciences gained 13.4 percent for the trading week ended Tuesday, reversing a 7-percent decline the week before. The firm led the seven companies in the BCW Index that gained ground for the tracking period. Stratagene led decliners in the Index with a drop of 9.3 percent. Its shares reached a 52-week low of $5.51 on Tuesday before closing at $5.67.

Overall, the Index gained .1 percent for the week. In comparison, the Dow Jones Industrial Average fell .5 percent, the Nasdaq dropped .3 percent, and the Nasdaq Biotech Index declined .7 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(June 27, 2006)
Last Price
(June 20, 2006)
% change
Agilent
A
30.44
32.18
-5.4
Applied Biosystems
ABI
32.15
30.50
5.4
Beckman
BEC
53.43
53.44
0.0
Bio-Rad
BIO
64.35
64.80
-0.7
Bruker
BRKR
5.24
4.62
13.4
Fisher Scientific
FSH
69.27
70.29
-1.5
GE
GE
32.88
33.70
-2.4
Harvard Bio
HBIO
4.31
4.09
5.4
Invitrogen
IVGN
64.89
64.19
1.1
Molecular Devices
MDCC
29.45
28.42
3.6
PerkinElmer
PKI
20.35
20.40
-0.2
Qiagen
QGEN
12.89
13.20
-2.3
Sigma
SIAL
70.70
70.03
1.0
Stratagene
STGN
5.67
6.25
-9.3
Thermo
TMO
34.03
34.82
-2.3
Waters
WAT
43.19
41.66
3.7
BCW Index Average
35.83
35.79
0.1
The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.